Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) CEO Jeff Shaner sold 90,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $1,035,000.00. Following the completion of the sale, the chief executive officer owned 2,561,972 shares of the company’s stock, valued at approximately $29,462,678. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Aveanna Healthcare Stock Performance
AVAH stock traded up $0.54 during midday trading on Monday, hitting $13.70. 5,364,375 shares of the company traded hands, compared to its average volume of 1,804,109. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $13.98. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The business has a 50 day simple moving average of $9.58 and a 200-day simple moving average of $7.92. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 11.14, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on Aveanna Healthcare
Institutional Trading of Aveanna Healthcare
A number of hedge funds have recently modified their holdings of AVAH. AQR Capital Management LLC increased its position in shares of Aveanna Healthcare by 21.2% during the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares during the period. Goldman Sachs Group Inc. boosted its stake in Aveanna Healthcare by 8.3% during the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after buying an additional 25,974 shares in the last quarter. Jane Street Group LLC increased its holdings in Aveanna Healthcare by 522.0% in the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after buying an additional 63,010 shares during the period. Creative Planning increased its holdings in Aveanna Healthcare by 15.1% in the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after buying an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Aveanna Healthcare by 65.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock valued at $828,000 after buying an additional 62,348 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
